期刊文献+

朊蛋白在喉鳞状细胞癌中的表达及临床意义 被引量:1

The Expression and Clinical Significance of Prion Protein in Laryngeal Squamous Cell Carcinoma
下载PDF
导出
摘要 目的:观察朊蛋白(PrPc)在喉鳞状细胞癌(简称鳞癌)中的表达情况,探讨PrPc与喉鳞癌临床病理特征的关系。方法:选取2000年6月至2013年4月收入院的喉鳞状细胞癌患者癌组织60例,喉鳞状上皮不典型增生患者病灶组织20例,非肿瘤患者的喉部正常粘膜组织20例。运用免疫组化(Envision)法检测PrPc在各组织中的表达水平,分析其与喉鳞癌患者的临床病理特征如:性别、年龄、临床分期、分型、病理分化程度、有无淋巴结转移的关系。结果:PrPc在喉鳞癌组织,喉不典型增生组织及正常粘膜组织中的表达阳性率分别为:55%(33/60),25%(5/20)及5%(1/20)。PrPc在3种组织中表达差异有统计学意义(<0.05)。并且PrPc在喉鳞癌中的表达阳性率随其病理分化程度的降低而升高(P<0.05)。PrPc在Ⅲ+Ⅳ期肿瘤组中的阳性表达率明显高于Ⅰ+Ⅱ期病例组(<0.05)。结论:PrPc的高表达与喉鳞癌的发生发展有密切关系,能为喉鳞癌的早期诊断和预后评估提供线索。 Objective: To observe the expression of prion protein(PrPc) in laryngeal squamous cell carcinomas(abbreviated as squamous cell carcinomas) and to explore the relationship between PrPcexpression and clinical pathologic features of laryngeal squamous cell carcinoma.Methods:Application of Immunohistochemistry(Envision)assay to detect the expression situation of PrPcin 60 cases of laryngeal squamous cell carcinoma,in 20 cases of laryngeal squamous atypical hyperplasia tissue and in 20 cases normal laryngeal mucosa taken from patients without tumor.in order to analyze the relationship between the expression level of PrPcand clinical pathological features of patients with laryngeal squamous cell carcinoma,such as,gender,age,clinical stages and pathological cell differentiation,and with or without lymph node metastasis.Results:The positive expression rate of PrPcin laryngeal squamous cell carcinomas organization,laryngeal squamous atypical hyperplasia tissue and normal laryngeal mucosa was 55%(33/60),25%(5/20) and 5%(1/20) respectively.There were statistically significant differences in expression of3 kinds of tissues(P〈0.05).With the decrease of pathological differentiation degree,the expression of PrPcin laryngeal squamous cell carcinomas organization rises(P〈0.05).The positive expression rate of PrPcin laryngeal squamous cell carcinoma tissues of the advanced stage patients group(III stage and IV stage) was significantly higher than that of laryngeal squamous cell carcinoma tissues of I and II stage patients group(P〈0.05).Conclusions:The high expression of PrPcwas closely associated with the genesis and development of laryngeal carcinomas.
出处 《农垦医学》 2016年第2期115-118,共4页 Journal of Nongken Medicine
关键词 朊蛋白 喉肿瘤 免疫组化 Prion protein(Pr Pc) Laryngeal squamous cell carcinomas Immunohistochemistry(Envision)assay
  • 相关文献

参考文献11

  • 1Colby DW,Prusiner SB.Prions [J]. Cold Spring Harb Perspect Biol, 2011,3(1) : 1-22.
  • 2Hong T. Infectious and non infectious dementia:Pon and Alzheimer's disease[M]. Beijing:Seience Press,2011:53-95.
  • 3Holada K,simak J,Risitano AM,et at. Activated platelets of patients with paroxysmal nocturnal hemoglobinuria express cellular prion protein[J]. Blood, 2002,100(3): 341-343.
  • 4Wang JH, Du JP, Li SJ, et al. Oetarepeat peptides of prion are essential for multidrug resistance in gastric cancer cells[J]. Dig Dis,2012,13(3): 143-152.
  • 5De Wit M,Jimenez CR,Carvalho B,et at. Cell surface proteomics identifies glucose transporter type 1 and prion protrin as cndidate biomarkers for colorectal adenoma to carcinoma progrssion[J]. Gut, 2012,61(6): 855-864.
  • 6Li WP,Zhang JN. The research progress of PrPc in digestive tumors[J]. Guangdong Med J,2014,35(20):3275-3278.
  • 7Wang WJ,Liu HL,Tan SL,et al.Effeet of cellular prian protein expression on proliferation and invasion of colorectal cancer eells[J].Chin J Exper Surg,2014,31(2):269-271.
  • 8Mehrpour M,Codogno P. Prion protein:from physiology to cancer biology[J]. Cancer Mtastasis Rev, 2007.26(3/4): 645-662.
  • 9韩彦玲,韩俊,李朝品,董小平.朊病毒病相关细胞凋亡[J].医学分子生物学杂志,2010,7(3):247-250. 被引量:2
  • 10Zheng YT,Huang ZH,Luo YW,et al.The high expression and clinical significance of PrPc in colorectal carcinoma [J]. Guangdong Med J, 2012,33(8) : 1132-1134.

二级参考文献33

  • 1WILL R G.The transmission of prions to humans[J].Acta PaediatrSuppl,1999,88:28-32.
  • 2SCOTT M R,WILL R,IRONSIDE J,et al.Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans[J].Proc Natl Acad Sci USA,1999,96:15137-42.
  • 3BELAY E D.Transmissible spongiform encephalopathies in human[J].Annu Rev Microbiol,1999,53:283-314.
  • 4PRUSINER S B.Prions(Nobel Lecture)[J].Proc Natl Acad Sci USA,1998,95:13363-13383.
  • 5GRAY F,DORANDEU A,WINGERTSMANN L,et al.Neuronal apoptosis in human prion diseases[J].Neuropathol Expl Neurol,1998,579(5):493.
  • 6RANA A,GNANESWARI D,BANSAL S,et al.Prion metal interaction:is prion pathogenesis a cause or a consequence of metal imbalance?[J].Chem Biol Interact,2009,181(3):282-291.
  • 7SOLFOROSI L,CRIADO J R,MCGAVERN D B,et al.Cross-linking cellular prion protein triggers neuronal apoptosis in vivo[J].Science,2004,303(5663):1514-1516.
  • 8BOUNHAR Y,ZHANG Y,GOODYER C G,et al.Prion protein protects human neurons against Bax-mediated apoptosis[J].J Biol Chem,2001,276(42):39145-39149.
  • 9MA J,WOLLMANN R,LINDQUIST S.Neurotoxicity andneurodegeneration when PrP accumulates in the cytosol[J].Science,2002,298:17812-17851.
  • 10WANG X,DONG C F,SHI Q,et al.Cytosolic prion protein induces apoptosis in human neuronal cell SH-SY5Y via mitochondrial disruption pathway[J].BMB Rep,2009,42(7):444-449.

共引文献10

同被引文献17

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部